Hypoglycemic, Hypolipidemic and Antioxidant Potentials of Ethanolic Stem Bark Extract of Anacardium occidentale in Streptozotocin-Induced Diabetic Rats
Authors:
- F. A BamisayeFBF. A Bamisaye
- R. A IbrahimRIR. A Ibrahim
- A.O. SulymanASA.O. Sulyman
- A.O. JubrilAJA.O. Jubril
- Olawale AjuwonOAOlawale Ajuwon
Open Access
- 30 June 2022
- journal article
- research article
- Published by Physiological Society of Nigeria in Nigerian Journal of Physiological Sciences
- Vol. 37 (1) , 137-145
Abstract
Diabetes mellitus is one of the most widespread diseases affecting the world’s population causing substantial morbidity, mortality and long-term complications. This study was designed to investigate possible hypoglycemic, hypolipidemic and antioxidant effect of ethanolic stem bark extract of Anacardium occidentale in streptozotocin (STZ)-induced diabetic rats. Twenty-eight STZ (60 mg/kg body weight)-induced diabetic, male albino rats were randomly distributed into Groups II-V (7 rats each) and orally administered with water, metformin (14.2 mg/kg), 200 mg/kg Anacardium occidentale extract and 400 mg/kg Anacardium occidentale extract respectively daily for 15 days. Group I rats were untreated with STZ and serves as control all under the same sham handling. Blood samples were taken for measurement of fasting blood glucose (FBG) and lipid profile. Liver and kidney tissue samples were taken for determination of glycemic indices (glucose and glycogen), as well as redox status markers such as malondialdehyde (MDA), total glutathione (GSH), activities of superoxide dismutase (SOD) and glutathione-s-transferase (GST). Results showed that treatment with 200 and 400 mg/kg Anacardium occidentale stem bark extract reversed hyperglycemia and hyperlipidemia induced by STZ similar to what was observed with the standard drug, metformin. Similarly, both extract concentration produced a significant reduction in MDA while the activity of SOD and GST, as well as concentration of GSH were elevated. This study suggested that ethanolic stem bark extract of Anacardium occidentale at 200 and 400 mg/kg can ameliorate diabetes and its associated complications via its hypoglycemic, hypolipidemic, antioxidant and free radical scavenging propertiesKeywords
This publication has 39 references indexed in Scilit:
- A Systematic Review of Oxidative Stress and Safety of Antioxidants in Diabetes: Focus on Islets and Their DefenseDiabetes & Metabolism Journal, 2013
- Hypoglycemic and hypolipidemic effects of Bersama engleriana leaves in nicotinamide/streptozotocin-induced type 2 diabetic ratsBMC Complementary and Alternative Medicine, 2012
- Risk Factor Treatment and Control in Relation to Coronary Disease Risk in the Spanish Population of the DARIOS StudyRevista Española de Cardiología (English Edition), 2011
- In vivo Antigenotoxic and Anticlastogenic Effects of Fresh and Processed Cashew ( Anacardium occidentale ) Apple JuicesJournal of Medicinal Food, 2011
- Identification of antimicrobial properties of cashew, Anacardium occidentale L. (Family Anacardiaceae)Journal of Applied Sciences and Environmental Management, 2010
- Resveratrol attenuates hyperglycemia-mediated oxidative stress, proinflammatory cytokines and protects hepatocytes ultrastructure in streptozotocin–nicotinamide-induced experimental diabetic ratsChemico-Biological Interactions, 2010
- Role of Mitochondrial Dysfunction in Insulin ResistanceCirculation Research, 2008
- Antidiabetic Effect ofAnacardium occidentale. Stem-Bark in Fructose-Diabetic RatsPharmaceutical Biology, 2005
- Preservation of insulin mRNA levels and insulin secretion in HIT cells by avoidance of chronic exposure to high glucose concentrations.Journal of Clinical Investigation, 1992
- Effect of insulin and oral glutathione on glutathione levels and superoxide dismutase activities in organs of rats with streptozocin-induced diabetesDiabetes, 1986